Daily Newsletter

08 August 2023

Daily Newsletter

08 August 2023

DeGen Medical and MRIguidance partner for surgical care technologies

The companies plan to combine 3D patient-specific implants, PurI-Ti technology and augmented reality with BoneMRI software.

RanjithKumar Dharma August 07 2023

DeGen Medical has collaborated with medical imaging software company MRIguidance to transform surgical care by leveraging advanced technologies.

The companies aim to establish new benchmarks in implant selection, surgical planning and postoperative care with the integration of 3D patient-specific implants, PurI-Ti technology and augmented reality with BoneMRI (synthetic CT) software that eliminates exposure to radiation.

Both entities are said to reshape surgical medicine by providing enhanced patient outcomes and enhancing the quality of life for people worldwide.

MRIguidance's BoneMRI software delivers detailed 3D anatomical reconstructions directly from only one magnetic resonance imaging (MRI) exam.

This is expected to be beneficial for adolescents.

It is said to be the first imaging technique that visualises both bone and soft tissue in a single examination without utilising harmful ionising radiation.

MRIguidance CEO Rik Jacobs said that he is excited to partner with DeGen Medical to introduce the solutions from both companies to the market in the US for optimising surgical workflows driven by innovations.

Patient-centric medical device development company DeGen Medical offers advanced implants and instrumentation solutions.

It is focused on the development of solutions for complex spinal disorders.

Augmented reality patient education boosts surgeon skills in planning and precision, leading to better patient satisfaction, according to the company.

Healthcare companies are hesitant to invest in the metaverse

The COVID-19 pandemic pushed the healthcare industry to rapid digitalization. Increased use of telehealth, telepresence systems, remote diagnostics, predictive AI, and wearable technology is changing how healthcare is delivered and improving patient outcomes. Emerging technologies such as AR and VR are becoming increasingly routine for professional training, surgical assistance, and treatment of psychological and neurological disorders. In the pharma and medical devices industries, AR, VR, and AI are rapidly accelerating drug discovery and manufacturing and generating supply chain efficiencies. New digital opportunities will look to build upon disruptive technologies. However, affordability is a limiting factor to widespread adoption. Per GlobalData estimates, the metaverse market is expected to grow at a CAGR of more than 33% between 2023 and 2030. Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close